Skip to main content
Log in

Linezolid best value in MRSA SSI

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Patanwala AE, Erstad BL, Nix DE.Cost-effectiveness of linezolid and vancomycin in the treatment of surgical site infections. Current Medical Research and Opinion 23: 185-193, No. 1, Jan 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Linezolid best value in MRSA SSI. Pharmacoecon. Outcomes News 524, 1 (2007). https://doi.org/10.2165/00151234-200705240-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705240-00001

Keywords

Navigation